Toward drugs derived from cannabis
- 1 April 1978
- journal article
- research article
- Published by Springer Nature in The Science of Nature
- Vol. 65 (4) , 174-179
- https://doi.org/10.1007/bf00450585
Abstract
Recent work aimed at the introduction of natural and synthetic cannabinoids as drugs is reviewed. Δ1-Tetrahydrocannabinol (Δ1-THC) is mainly investigated as a potential drug against glaucoma and asthma, and as an antiemetic agent in cancer chemotherapy. Cannabidiol is being tried in the clinic against epilepsy and as a hypnotic. Numerous synthetic cannabinoids are currently being investigated as analgetics and as sedative-relaxants.Keywords
This publication has 46 references indexed in Scilit:
- Inhibition of a Lymphocyte Membrane Enzyme by Δ 9 -Tetrahydrocannabinol in VitroScience, 1977
- Some Historical Aspects of MarijuanaClinical Toxicology, 1977
- 9-Nor-9-hydroxyhexahydrocannabinols. Synthesis, some behavioral and analgesic properties, and comparison with the tetrahydrocannabinolsJournal of Medicinal Chemistry, 1976
- Marihuana, tetrahydrocannabinol and T-cell functionLife Sciences, 1976
- Structure-Activity Relationships in Man of Cannabis Constituents, and Homologs and Metabolites of Δ9-TetrahydrocannabinolPharmacology, 1974
- Cannabidiol and Cannabis sativa extract protect mice and rats against convulsive agentsJournal of Pharmacy and Pharmacology, 1973
- Suppression of the Cyclic Surge of Luteinizing Hormone Secretion and of Ovulation in the Rat by Δ1-TetrahydrocannabinolNature, 1973
- Effects of Delta–9–tetrahydrocannabinol on Cyclopropane MAC in the RatAnesthesiology, 1973
- Metabolism of Δ1(6)-Tetrahydro-cannabinol, an Active Marihuana ConstituentNature, 1970
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964